Metabolism of l‐Tryptophan to Kynurenate and Quinolinate in the Central Nervous System

Effects of 6‐Chlorotryptophan and 4‐Chloro‐3‐Hydroxyanthranilate

Dmitry B. Naritsin, Kuniaki Saito, S. P. Markey, Cai Y. Chen, Melvyn P. Heyes

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Abstract: The metabolism of l‐tryptophan to the neuroactive kynurenine pathway metabolites, l‐kynurenine, kynurenate and quinolinate, and the effects of two inhibitors of quinolinate synthesis (6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate) were investigated by mass spectrometric assays in cultured cells and in vivo. Cell lines obtained from astrocytoma, neuroblastoma, macrophage/monocytes, lung, and liver metabolized l‐[13C6]‐tryptophan to l‐[13C6]kynurenine and [13C6]kynurenate, particularly after indoleamine‐2,3‐dioxygenase induction by interferon‐γ. Kynurenine aminotransferase activity was measurable in all cell types examined but was unaffected by interferon‐γ. These results suggest that many cell types can be sources of kynurenate following immune activation. In vivo synthesis of l‐[13C6]kynurenine and [13C6]kynurenate from l‐[13C6]tryptophan was studied in the CSF of macaques infected with poliovirus, as a model of inflammatory neurologic disease. The effects of 6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate on the synthesis of kynurenate were different. 6‐Chlorotryptophan attenuated formation of l‐[13C6]kynurenine and [13C6]kynurenate and was converted to 4‐chlorokynurenine and 7‐chlorokynurenate. It may be an effective prodrug for the delivery of 7‐chlorokynurenate, which is a potent antagonist of NMDA receptors. In contrast, 4‐chloro‐3‐hydroxyanthranilate did not reduce accumulation of l‐[13C6]kynurenine and [13C6]kynurenate. 6‐Chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate are useful tools to manipulate concentrations of quinolinate and kynurenate in the animal models of neurologic disease to evaluate physiological roles of these neuroactive metabolites.

Original languageEnglish
Pages (from-to)2217-2226
Number of pages10
JournalJournal of Neurochemistry
Volume65
Issue number5
DOIs
Publication statusPublished - 01-01-1995
Externally publishedYes

Fingerprint

Kynurenic Acid
Quinolinic Acid
Neurology
Metabolism
Kynurenine
Central Nervous System
kynurenine-oxoglutarate transaminase
Metabolites
Nervous System Diseases
Tryptophan
Interferons
Cells
Poliovirus
Macrophages
Astrocytoma
Prodrugs
Macaca
N-Methyl-D-Aspartate Receptors
Neuroblastoma
Liver

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

@article{4190ab89b66a4b0395a5a1cccb722a79,
title = "Metabolism of l‐Tryptophan to Kynurenate and Quinolinate in the Central Nervous System: Effects of 6‐Chlorotryptophan and 4‐Chloro‐3‐Hydroxyanthranilate",
abstract = "Abstract: The metabolism of l‐tryptophan to the neuroactive kynurenine pathway metabolites, l‐kynurenine, kynurenate and quinolinate, and the effects of two inhibitors of quinolinate synthesis (6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate) were investigated by mass spectrometric assays in cultured cells and in vivo. Cell lines obtained from astrocytoma, neuroblastoma, macrophage/monocytes, lung, and liver metabolized l‐[13C6]‐tryptophan to l‐[13C6]kynurenine and [13C6]kynurenate, particularly after indoleamine‐2,3‐dioxygenase induction by interferon‐γ. Kynurenine aminotransferase activity was measurable in all cell types examined but was unaffected by interferon‐γ. These results suggest that many cell types can be sources of kynurenate following immune activation. In vivo synthesis of l‐[13C6]kynurenine and [13C6]kynurenate from l‐[13C6]tryptophan was studied in the CSF of macaques infected with poliovirus, as a model of inflammatory neurologic disease. The effects of 6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate on the synthesis of kynurenate were different. 6‐Chlorotryptophan attenuated formation of l‐[13C6]kynurenine and [13C6]kynurenate and was converted to 4‐chlorokynurenine and 7‐chlorokynurenate. It may be an effective prodrug for the delivery of 7‐chlorokynurenate, which is a potent antagonist of NMDA receptors. In contrast, 4‐chloro‐3‐hydroxyanthranilate did not reduce accumulation of l‐[13C6]kynurenine and [13C6]kynurenate. 6‐Chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate are useful tools to manipulate concentrations of quinolinate and kynurenate in the animal models of neurologic disease to evaluate physiological roles of these neuroactive metabolites.",
author = "Naritsin, {Dmitry B.} and Kuniaki Saito and Markey, {S. P.} and Chen, {Cai Y.} and Heyes, {Melvyn P.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1046/j.1471-4159.1995.65052217.x",
language = "English",
volume = "65",
pages = "2217--2226",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

Metabolism of l‐Tryptophan to Kynurenate and Quinolinate in the Central Nervous System : Effects of 6‐Chlorotryptophan and 4‐Chloro‐3‐Hydroxyanthranilate. / Naritsin, Dmitry B.; Saito, Kuniaki; Markey, S. P.; Chen, Cai Y.; Heyes, Melvyn P.

In: Journal of Neurochemistry, Vol. 65, No. 5, 01.01.1995, p. 2217-2226.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metabolism of l‐Tryptophan to Kynurenate and Quinolinate in the Central Nervous System

T2 - Effects of 6‐Chlorotryptophan and 4‐Chloro‐3‐Hydroxyanthranilate

AU - Naritsin, Dmitry B.

AU - Saito, Kuniaki

AU - Markey, S. P.

AU - Chen, Cai Y.

AU - Heyes, Melvyn P.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Abstract: The metabolism of l‐tryptophan to the neuroactive kynurenine pathway metabolites, l‐kynurenine, kynurenate and quinolinate, and the effects of two inhibitors of quinolinate synthesis (6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate) were investigated by mass spectrometric assays in cultured cells and in vivo. Cell lines obtained from astrocytoma, neuroblastoma, macrophage/monocytes, lung, and liver metabolized l‐[13C6]‐tryptophan to l‐[13C6]kynurenine and [13C6]kynurenate, particularly after indoleamine‐2,3‐dioxygenase induction by interferon‐γ. Kynurenine aminotransferase activity was measurable in all cell types examined but was unaffected by interferon‐γ. These results suggest that many cell types can be sources of kynurenate following immune activation. In vivo synthesis of l‐[13C6]kynurenine and [13C6]kynurenate from l‐[13C6]tryptophan was studied in the CSF of macaques infected with poliovirus, as a model of inflammatory neurologic disease. The effects of 6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate on the synthesis of kynurenate were different. 6‐Chlorotryptophan attenuated formation of l‐[13C6]kynurenine and [13C6]kynurenate and was converted to 4‐chlorokynurenine and 7‐chlorokynurenate. It may be an effective prodrug for the delivery of 7‐chlorokynurenate, which is a potent antagonist of NMDA receptors. In contrast, 4‐chloro‐3‐hydroxyanthranilate did not reduce accumulation of l‐[13C6]kynurenine and [13C6]kynurenate. 6‐Chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate are useful tools to manipulate concentrations of quinolinate and kynurenate in the animal models of neurologic disease to evaluate physiological roles of these neuroactive metabolites.

AB - Abstract: The metabolism of l‐tryptophan to the neuroactive kynurenine pathway metabolites, l‐kynurenine, kynurenate and quinolinate, and the effects of two inhibitors of quinolinate synthesis (6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate) were investigated by mass spectrometric assays in cultured cells and in vivo. Cell lines obtained from astrocytoma, neuroblastoma, macrophage/monocytes, lung, and liver metabolized l‐[13C6]‐tryptophan to l‐[13C6]kynurenine and [13C6]kynurenate, particularly after indoleamine‐2,3‐dioxygenase induction by interferon‐γ. Kynurenine aminotransferase activity was measurable in all cell types examined but was unaffected by interferon‐γ. These results suggest that many cell types can be sources of kynurenate following immune activation. In vivo synthesis of l‐[13C6]kynurenine and [13C6]kynurenate from l‐[13C6]tryptophan was studied in the CSF of macaques infected with poliovirus, as a model of inflammatory neurologic disease. The effects of 6‐chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate on the synthesis of kynurenate were different. 6‐Chlorotryptophan attenuated formation of l‐[13C6]kynurenine and [13C6]kynurenate and was converted to 4‐chlorokynurenine and 7‐chlorokynurenate. It may be an effective prodrug for the delivery of 7‐chlorokynurenate, which is a potent antagonist of NMDA receptors. In contrast, 4‐chloro‐3‐hydroxyanthranilate did not reduce accumulation of l‐[13C6]kynurenine and [13C6]kynurenate. 6‐Chlorotryptophan and 4‐chloro‐3‐hydroxyanthranilate are useful tools to manipulate concentrations of quinolinate and kynurenate in the animal models of neurologic disease to evaluate physiological roles of these neuroactive metabolites.

UR - http://www.scopus.com/inward/record.url?scp=0028971636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028971636&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.1995.65052217.x

DO - 10.1046/j.1471-4159.1995.65052217.x

M3 - Article

VL - 65

SP - 2217

EP - 2226

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -